Cosmetics Toiletries, March 17 2020
The FDA’s latest sunscreen scrutiny is focused on the test protocol for the Maximal Usage Trial study (MUsT). This human pharmacokinetic test measures the amount of absorption of a drug into the body. What else might it tell us?
In a January 2020 meeting at the New York Chapter of Society of Cosmetic Chemists (NYSCC), Howard Epstein, Ph.D., director of technical services for EMD Performance Materials in Philadelphia, provided an update regarding the U.S. Food and Drug Administration’s (FDA’s) proposed changes to Sunscreen Innovation Act, introduced in February 2019.
Nanoparticles have a bad reputation among the general public. There is great uncertainty as to…
In an ever-changing and increasingly competitive hair care market, sensory profiling is a real asset…
Taobé Consulting specializes in helping cosmetic brands navigate complex European and UK regulatory frameworks, providing…